Clinical Trial Update: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of roflumilast and pioglitazone in adults with nonalcoholic steatohepatitis was terminated; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Actos (Pioglitazone)
• Daliresp (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Nonalcoholic Steatohapatitis | Phase 2 | Status: TERMINATED | Results posted: 2016-02-23